Accuracy of Echocardiography to Evaluate Pulmonary Vascular and RV Function During Exercise by Claessen, Guido et al.
J A C C : C A R D I O V A S C U L A R I M A G I N G V O L . - , N O . - , 2 0 1 5
ª 2 0 1 5 B Y T H E AM E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N DA T I O N I S S N 1 9 3 6 - 8 7 8 X / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . h t t p : / / d x . d o i . o r g / 1 0 . 1 0 1 6 / j . j c m g . 2 0 1 5 . 0 6 . 0 1 8Accuracy of Echocardiography to
Evaluate Pulmonary Vascular and RV
Function During Exercise
Guido Claessen, MD, PHD,*y Andre La Gerche, MD, PHD,*z Jens-Uwe Voigt, MD, PHD,*y
Steven Dymarkowski, MD, PHD,yx Frédéric Schnell, MD,*k Thibault Petit, MD,*y Rik Willems, MD, PHD,*y
Piet Claus, MSC, PHD,* Marion Delcroix, MD, PHD,y{ Hein Heidbuchel, MD, PHD#ABSTRACTFro
zB
Be
KU
wa
cli
ScOBJECTIVES We compared exercise echocardiography and exercise cardiac magnetic resonance imaging with simul-
taneous invasive pressure registration (ExCMRip) for the assessment of pulmonary vascular and right ventricular (RV)
function.
BACKGROUND Exercise echocardiography may enable early diagnosis of pulmonary vascular disease, but its accuracy
is untested.
METHODS Exercise imaging was performed in 61 subjects (19 athletes, 9 healthy nonathletes, 8 healthy BMPR2 [bone
morphogenetic protein receptor type II] mutation carriers, 5 patients with new or worsening dyspnea after acute pul-
monary embolism, and 20 patients with chronic thromboembolic pulmonary hypertension). Echocardiographic variables
included mean pulmonary artery pressure (mPAP) and systolic pulmonary artery pressure (sPAP), cardiac output (CO), RV
fractional area change, tricuspid annular systolic excursion, and RV end-systolic pressure-area ratio as a surrogate
measure of RV contractile reserve. ExCMRip provided measurements of CO, RV ejection fraction, mPAP, sPAP, and RV
end-systolic pressure-volume ratio at rest and during exercise. Abnormal pulmonary vascular reserve was deﬁned as
mPAP/CO slope >3 mm Hg/l/min by ExCMRip.
RESULTS Echocardiographic determination of mPAP/CO was possible in 53 of 61 subjects (87%). mPAP/CO by
echocardiography was higher than that obtained by ExCMRip (þ0.9 mm Hg/l/min; 95% limits of agreement, 3.6 to
5.4), but enabled accurate identiﬁcation of patients with abnormal pulmonary vascular reserve (area under the
receiver-operating characteristic curve, 0.88 [95% conﬁdence interval (CI): 0.77 to 1.00, p < 0.0001]). Simpliﬁed
relationships between sPAP and exercise intensity had similar accuracy in identifying subjects with pulmonary vascular
disease (area under the receiver-operating characteristic curve, 0.95 [95% CI: 0.88 to 1.01], p < 0.0001). RV fractional
area change by echocardiography correlated strongly with RV ejection fraction by ExCMRip, whereas a moderate
correlation was found between tricuspid annular systolic excursion and RV ejection fraction. A moderate correlation
was found between ratios of peak exercise to resting RV end-systolic pressure-area ratio and RV end-systolic pressure-
volume ratio (r ¼ 0.64, p < 0.0001).
CONCLUSIONS Echocardiographic estimates of RV and pulmonary vascular function are feasible during exercise and
identify pathology with reasonable accuracy. They represent valid screening tools for the identiﬁcation of pulmonary
vascular disease in routine clinical practice. (J Am Coll Cardiol Img 2015;-:-–-) © 2015 by the American College of
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2T here is broad agreement thatexercise-induced pulmonary hyper-tension is an important clinical
ﬁnding with diagnostic and prognostic utility
in a broad range of cardiac and pulmonary
vascular conditions (1). Echocardiography
remains the primary screening tool for pul-
monary vascular disease. However, echocar-
diographic estimation of pulmonary artery
pressure (PAP) during exercise is not routine
because of concerns regarding the impreci-
sion and lack of standardization of exercise
measures (2,3).
Recent studies demonstrated a consistent
nearly linear relationship between changes
in PAP and cardiac output (CO) (1,4–6) with
an expected increase in mean pulmonary
artery pressure (mPAP) ofw1 to 2 mm Hg/l/min
of CO representing a normal pulmonary
vascular response and any value greater than
3 mm Hg/l/min being suggestive of pathol-
ogy (1). This represents a more physiological
appraisal than single peak exercise measures
as the ﬂow-dependent characteristics of the
circulation are encompassed in the separa-
tion of normal from abnormal. Although the
advantages of an approach incorporating
PAP in relation to CO or exercise intensity are
now well accepted, the accuracy and preci-
sion of noninvasive estimates of these re-lationships remain to be proved against gold standard
measures.
We sought to validate echocardiographic mea-
sures of PAP and CO during intense exercise
compared with the reference standards of invasive
PAP and exercise cardiac magnetic resonance (CMR),
having previously validated this against direct Fick
measurements of CO (7). Thus, echocardiographic
measures were compared with those from a hybrid
invasive CMR technique in healthy subjects and
patients with pulmonary vascular pathology. Fur-
thermore, the use of CMR as a gold standard for
right ventricular (RV) measures enables us to
simultaneously validate echocardiographic measures
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SUBJECTS. Sixty-one subjects underwent evaluation
with exercise echocardiography and exercise CMR
imaging combined with invasive PAP estimates
(subsequently referred to as exercise cardiac mag-
netic resonance imaging with simultaneous invasive
pressure registration [ExCMRip]) within a 24-h time-
frame. The study population comprised a range of
healthy subjects and patients with pulmonary
vascular disease including 19 endurance athletes, 9
healthy nonathletes, 8 asymptomatic carriers of a
mutation linked to the development of pulmonary
arterial hypertension (BMPR2 [bone morphogenetic
protein receptor type II] mutation), 5 subjects with
persisting exertional dypsnea after pulmonary em-
bolism, 14 patients with chronic thromboembolic
pulmonary hypertension (CTEPH), and 6 patients
undergoing routine hemodynamic evaluation 6
months after pulmonary endarterectomy (post-PEA).
STUDY DESIGN. Cardiopulmonary exercise testing
was performed on an upright cycle ergometer to
determine maximal exercise power. On the same day,
echocardiography was performed with subjects at
both rest and during incremental exercise at 25%,
50%, and 66% of maximal upright exercise power, as
previously described (7,8).
Within 24 h after exercise echocardiography, all
subjects underwent exercise ExCMRip at the same
workloads as for the echocardiography protocol.
Before exercise, a 7-F pulmonary artery catheter was
inserted in the internal jugular vein and guided under
ﬂuoroscopy to the proximal right main pulmonary
artery. In the CMR suite, these catheters were
attached to CMR-compatible pressure transducers
that were connected to a PowerLab recording system
(AD Instruments, Oxford, United Kingdom). Pressure
measurements were continuously recorded during
the exercise CMR protocol and analyzed off-line using
LabChart v6.1.1 (AD Instruments). All pressure mea-
surements were averaged over 10 consecutive cardiac
cycles during unrestricted respiration (1).
ECHOCARDIOGRAPHY. Resting and exercise echo-
cardiography was performed on a semisupine cycle(Medtronic, Boston Scientiﬁc, Biotronik, St. Jude
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FIGURE 1 PAP Measurement Using Colloid Enhancement of the Tricuspid Regurgita-
tion Signal
(A) Administration of agitated colloid enhancement (white arrow) enables pressure
estimation during exercise in a patient in whom no tricuspid regurgitant signal could be
obtained without contrast. The dotted green line depicts the estimation of systolic pul-
monary artery pressure (sPAP) by echocardiography, whereas systemic artery pressure
(SAP) and pulmonary artery pressure (PAP) denote invasive SAP and PAP measurements.
(B) Potential for signiﬁcant pressure overestimation (red dotted line and marker) because
of noisy signal artifacts related to contrast enhancement. Careful measurement of only the
enhanced signal with a shape similar to the normal tricuspid regurgitation ﬂow velocity
proﬁle (green curve) yields sPAP values similar to those derived invasively.
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . - , N O . - , 2 0 1 5 Claessen et al.
- 2 0 1 5 :- –- Echocardiography for Pulmonary Vascular and RV Function
3ergometer (Easystress, Ecogito Medical sprl, Liege,
Belgium). Images were acquired using a Vivid E9 ul-
trasound system (GE Vingmed Ultrasound AS, Horten,
Norway) and analyzed off-line using EchoPAC version
112 (GE Vingmed Ultrasound AS).
Both at rest and during exercise, systolic pulmo-
nary artery pressure (sPAP) was estimated from the
maximal transtricuspid regurgitant velocities with
colloid contrast enhancement (Figure 1), without the
addition of right atrial pressure estimates (4,9), as
previous investigations failed to demonstrate reliable
accuracy, and no studies have validated estimates
during exercise (10). mPAP was estimated from sPAP
measurements using the Chemla formula: mPAP ¼
0.61  sPAP þ 2 (11). CO was derived from the
Doppler-estimated stroke volume (SV) using the ve-
locity time integral of ﬂow through the left ventric-
ular outﬂow tract (5). RV fractional area change
(Figure 2A) and tricuspid annular plane systolic
excursion were calculated from a single-plane
4-chamber view as described previously (9). The
right ventricular end-systolic pressure-area ratio
(RVESPAR), a surrogate of RV contractility, was
calculated as sPAP divided by RV end-systolic area
(9). The ratio of peak exercise RVESPAR divided by
resting RVESPAR was calculated as a surrogate of RV
contractile reserve.
CMR EQUIPMENT, IMAGE ACQUISITION, AND ANALYSIS.
Biventricular volumes were measured during supine
cycling exercise using a real-time CMR method that
we previously validated against invasive standards
(7). In brief, subjects performed supine exercise
within the CMR bore using a cycle ergometer with
adjustable electronic resistance (Lode, Groningen, the
Netherlands). Images were acquired with a Philips
Achieva 1.5-T CMR with a 5-element phased-array coil
(Philips Medical Systems, Best, the Netherlands).
Using an in-house–developed software program
(RightVol, Leuven, Belgium), left ventricular and RV
end-diastolic volume, end-systolic volume, and SV
were calculated by a summation of disks (Figure 2B).
CO was measured as the product of SV and heart rate,
whereas ejection fraction (EF) was calculated as SV/
end-diastolic volume. Similar to RVESPAR, the
ExCMRip-derived RVESPVR was calculated as sPAP/
RV end-systolic volume, whereas the ratio of peak
exercise to resting RVESPVR was used to estimate RV
contractile reserve.
STATISTICAL ANALYSIS. Data were analyzed using
SPSS version 22 software (IBM, Chicago, Illinois).
Gaussian distribution of all continuous variables was
tested using a Kolmogorov-Smirnov test. Descriptive
data for continuous variables are presented as mean SD or as median (25% and 75% percentiles) where
appropriate. Categorical data were compared using
the Fisher exact test.
The relationships between individual PAP, CO,
and workload were determined using linear re-
gression analysis (8). A Bland-Altman analysis
was used to assess the accuracy and precision of
echocardiography-derived hemodynamics compared
with ExCMRip (12). The bias, SD, and 95% limits of
agreement were reported. Receiver-operating char-
acteristic (ROC) curves were constructed to determine
the diagnostic accuracy of echocardiography-derived
pulmonary vascular pressure/ﬂow and pressure/
workload relationships to detect an abnormal pul-
monary vascular reserve, deﬁned as an mPAP-CO
slope >3 mm Hg/l/min by ExCMRip. Similarly, ROC
curves were constructed to assess the diagnostic
FIGURE 2 Assessment of RV Function During Exercise by Echocardiography and ExCMRip
End-diastolic and end-systolic image frames are depicted at peak exercise in a patient with impaired right ventricular (RV) functional reserve due to chronic
thromboembolic pulmonary hypertension. From these images, RV fractional area change (FAC) is calculated using echocardiography (A), whereas a sum-
mation of disks is used to calculate RV ejection fraction (EF) by ExCMRip (B). See Online Video 1. EDA ¼ end-diastolic area; EDV ¼ end-systolic volume;
ESA ¼ end-systolic area; ESV ¼ end-systolic volume; ExCMRip ¼ exercise cardiac magnetic resonance imaging with simultaneous invasive pressure regis-
tration; HR ¼ heart rate.
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4accuracy of RVESPAR to identify CTEPH and post-PEA
patients in whom RV contractile reserve during ex-
ercise is impaired (8). Diagnostic accuracy was
quantiﬁed by the area under the ROC curve.
The impact of exercise on the sPAP-mPAP rela-
tionship was evaluated by a linear mixed model that
included sPAP, condition (rest vs. peak exercise),
and their interaction as ﬁxed effects. To account for
the repeated nature of the data, an unstructured
variance-covariance matrix was included in the
model. A p value <0.05 was considered statistically
signiﬁcant.
RESULTS
The clinical characteristics of the 61 subjects are
summarized in Table 1.
ASSESSMENT OF PAP BY ECHOCARDIOGRAPHY
VERSUS INVASIVE MEASURES. At rest, echocardio-
graphic measures of sPAP were possible in 57 of 61
subjects (93%). The number of subjects in whom a
Doppler echocardiographic estimate of sPAP could
be obtained decreased to 46 (75%), 49 (80%), and42 (69%) for low-, moderate- and peak-intensity ex-
ercise, respectively.
At rest, an excellent correlation was found between
echocardiographic and invasive measures, for both
sPAP and mPAP (Figure 3A). No signiﬁcant bias was
observed for echocardiographic estimation relative to
invasive sPAP, whereas mPAP calculated from
echocardiography-derived sPAP using the Chemla
formula were higher than invasively measured mPAP
(Table 2). The difference in sPAP was <10 mm Hg in
41 of 57 subjects (72%) and >20 mm Hg in 5 subjects
(9%). Similarly, for mPAP, the difference was
<10 mm Hg in 47 subjects (83%) and >20 mm Hg in
1 subject (2%).
At peak exercise, echocardiography-derived sPAP
and mPAP correlated strongly with invasive measures
(Figure 3A). There was no signiﬁcant bias between
invasive and echocardiographic measures of sPAP at
peak exercise, whereas echocardiography over-
estimated mPAP (Table 2). The difference in peak
exercise invasive and echocardiography-derived
sPAP was <10 mm Hg in 20 of 42 subjects (48%) and
>20 mm Hg in 4 subjects (10%).
TABLE 1 Clinical Characteristics
Age, yrs 46 (32, 57)
Male 46 (75)
Height, cm 175  12
Weight, kg 79  14
BMI, kg/m2 26.1  4.8
Subjects
Endurance athletes 19
Healthy nonathletes 9
BMPR2 mutation carriers 8
Post-PE patients 5
CTEPH patients 14
Post-PEA patients 6
Values are median (25th, 75th percentile), n (%), or mean  SD.
BMI ¼ body mass index; BMPR2 ¼ bone morphogenetic protein receptor type II;
CTEPH ¼ chronic thromboembolic pulmonary hypertension; PE ¼ pulmonary
embolism; PEA ¼ pulmonary endarterectomy.
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5Considering all workloads, echocardiographic es-
timates of mPAP were higher than those measured
invasively (þ5.1  6.9 mm Hg; p < 0.0001), whereas
the bias in sPAP was not statistically signiﬁcant (mean
bias þ1.6  11.6 mm Hg; p ¼ 0.055). The bias in mPAP
remained signiﬁcant when CTEPH and post-PEA pa-
tients were excluded (mean bias þ4.9  6.7 mm Hg;
p < 0.0001). Analysis of the relationship between
invasive sPAP and mPAP revealed an excellent linear
correlation (mPAP ¼ 0.54  sPAP þ 1.9, R2 ¼ 0.96; p <
0.0001). When the values at each exercise intensity
were considered separately, the relationship between
invasive sPAP and mPAP was very similar (Online
Table 1), indicating consistency of the relationship
throughout exercise. Using the regression equation
derived from our data (mPAP ¼ 0.54  sPAP þ 1.9)
in preference to the Chemla formula, there was
only minimal bias between echocardiography and
ExCMRip measures of mPAP (þ1.3  6.7 mm Hg;
p ¼ 0.008) with 95% limits of agreement of 11.8 to
14.4 mm Hg. Estimation of sPAP by echocardiography
did not include addition of right atrial pressure such
that sPAP measurements by echocardiography
equaled invasively derived sPAP minus right atrial
pressure. When this formula was used to compare
echocardiographic and invasive measurements, a
small but consistent bias was seen (Online Figure 1),
demonstrating that some of the inaccuracy between
echocardiography and invasive measurements was
due to exercise-induced increases in right atrial
pressure in the pulmonary hypertension patients.
ASSESSMENT OF PULMONARY VASCULAR RESERVE.
At rest, CO measured by echocardiography was sig-
niﬁcantly lower than values using ExCMRip due
to underestimation of SV (Table 2, Figure 3B). The
difference in SV remained similar from rest to peak
exercise, whereas the difference in CO increased
because peak exercise heart rate was lower during
exercise echocardiography (141  24 beats/min vs.
124  19 beats/min; p < 0.0001).
One healthy subject (4%), 1 BMPR2 carrier (13%), 3
post-pulmonary embolism patients (60%), 12 CTEPH
patients (86%), and 6 post-PEA patients (100%) had
abnormal pulmonary vascular reserve as deﬁned by
the mPAP/CO cutoff of >3 mm Hg/l/min by ExCMRip
(Online Figure 2). Multipoint PAP/CO slope determi-
nation by echocardiography was possible in 53 of 61
subjects (87%), whereas the success rate in obtaining
peak exercise PAP measurements alone was 69%
(p ¼ 0.028). As depicted in Figure 4, echocardiography
had good accuracy and precision for the assessment
of individual mPAP/CO slopes. For the detection of
the presence of abnormal pulmonary vascular
reserve, the area under the ROC curve was 0.88 (95%conﬁdence interval [CI]: 0.77 to 1.00; p < 0.0001), and
mPAP/CO by echocardiography of 3.2 mm Hg/l/min
was identiﬁed as the most favorable threshold, with
88% sensitivity and 81% speciﬁcity.
We also evaluated the use of simpliﬁed relation-
ships by plotting sPAP against CO and exercise in-
tensity in Watts. As shown by Online Figure 3, we
found a consistent linear relationship between CO
and exercise intensity with limited interindividual
variability (CO ¼ 0.07  power [in Watts] þ 6.8).
ExCMRip-derived mPAP/CO slopes correlated strongly
with echocardiography-derived sPAP/W and sPAP/CO
slopes (Figure 4). ROC analysis showed that cutoff
values of >0.47 mm Hg/W for sPAP/W and >5.2
mm Hg/l/min for sPAP/CO slopes had a sensitivity of
86% and 88% and a speciﬁcity of 94% and 81% to
depict abnormal pulmonary vascular reserve (area
under the curve, 0.95 [95% CI: 0.88 to 1.01] and 0.88
[95% CI: 0.77 to 1.0], respectively; p < 0.0001).
EVALUATION OF RV CONTRACTILE RESERVE. The
number of patients in whom tricuspid annular plane
systolic excursion and RV fractional area change
could be obtained decreased from 60 (98%) and
57 (93%) at rest to 53 (87%) and 50 (82%) at peak ex-
ercise, respectively.
At both rest and peak exercise, the correlation be-
tween RVEF and RV fractional area change was higher
than that between RVEF and tricuspid annular plane
systolic excursion (Figure 5). An example of exercise
echocardiography and ExCMRip for the assessment of
RV functional reserve in a CTEPH patient is provided
in Figure 2 and Online Video 1.
The association between RVESPAR and RVESPVR
was strong at rest and moderate at peak exercise
(Figure 5). Overall, an excellent correlation was found
when either sPAP or mPAP was used to calculate
FIGURE 3 Assessment of PAP, Stroke Volume, and Cardiac Output
Assessment of PAP (A) and stroke volume and cardiac output by echocardiography and by ExCMRip (B). Left panels depict correlation coefﬁcients of resting (solid lines)
and peak exercise data (dashed lines). In the Bland-Altman plots (right panels), the mean bias and 95% limits of agreement of resting and exercise data are presented.
Echo ¼ echocardiography; mPAP ¼ mean pulmonary artery pressure; other abbreviations as in Figures 1 and 2.
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6RVESPVR (R2 ¼ 0.86; p < 0.0001). The correlation
remained excellent when only CTEPH and post-PEA
patients were considered (R2 ¼ 0.89). The ratio of
peak exercise to resting RVESPAR correlated moder-
ately with the ratio of peak exercise to resting
RVESPVR (Figure 5). At rest, CTEPH and post-PEA
patients had higher RVESPVR and RVESPAR
compared with the other groups (0.73  0.24 mm Hg/ml
vs. 0.32  0.23 mm Hg/ml and 3.56  1.05 mm Hg/cm2
vs. 2.31  1.27 mm Hg/cm2; p < 0.01). However, the
ratios of peak exercise to resting RVESPVR and
RVESPAR were signiﬁcantly reduced in CTEPH and
post-PEA patients (1.45  0.30 vs. 3.30  1.09 and 1.45
 0.38 vs. 2.84  1.24; both p < 0.01), indicating that
the exercise-induced increase in RV contractility was
impaired. The RVESPVR ratio of 2.01 from rest to peak
exercise had a sensitivity and a speciﬁcity for iden-
tifying CTEPH and post-PEA patients of 100% and
98% (AUC 0.99 [95% CI: 0.98 to 1.00]), respectively,
whereas a peak exercise to resting RVESPAR ratio of1.64 had a respective sensitivity and speciﬁcity of
82% and 96% (AUC 0.94 [95% CI: 0.87 to 1.02])
(Figure 6).
DISCUSSION
We demonstrate that measures obtained during ex-
ercise echocardiography can provide a sufﬁciently
robust estimate of PAP changes during exercise and
CO to justify inclusion in daily clinical practice as a
means of identifying abnormalities in pulmonary
vascular function. Determination of PAP/CO slopes by
echocardiography was feasible in the majority of
subjects and had good accuracy for identifying
abnormal vascular reserve. Furthermore, simpliﬁed
relationships between sPAP and exercise intensity
measured in Watts can also be used to identify pa-
thology and may represent a simpler clinical tool by
avoiding the need for CO quantiﬁcation. Finally, this
is the ﬁrst study to validate echocardiographic
TABLE 2 Assessment of Pulmonary Arterial Pressures, Cardiac Output and Pressure/Flow and Pressure/Workload Relationships by
Echocardiography Versus Combined CMR/Invasive Measures
ExCMRip Echocardiography Bias
p Value
of Bias
SD of
Difference
Limits of
Agreement
sPAP, mm Hg
Rest 36.1  25.9 37.7  22.9 1.7 0.21 10.0 17.9 to 21.2
Peak exercise 61.9  31.4 64.8  25.1 2.9 0.17 13.6 23.7 to 29.6
mPAP, mm Hg
Rest 21.0  14.2 25.0  14.0 4.1 <0.0001 6.1 7.9 to 16.0
Peak exercise 34.2  17.2 41.5  15.3 7.3 <0.0001 7.4 7.1 to 21.7
CO, l/min
Rest 6.5  1.8 5.5  1.5 1.0 <0.0001 1.6 4.0 to 2.1
Peak exercise 16.6  7.2 12.4  4.3 4.2 <0.0001 4.0 12.0 to 3.7
SV, ml
Rest 98.0  32.7 80.4  24.5 17.6 <0.0001 20.6 58.1 to 23.0
Peak exercise 114.9  38.7 100.0  28.0 15.0 <0.0001 21.5 57.2 to 27.2
mPAP/CO, mm Hg/l/min 3.3  3.6 4.1  3.8 0.90 0.007 2.3 3.6 to 5.4
sPAP/CO, mm Hg/l/min 5.9  6.4 6.8  6.2 0.85 0.18 4.6 8.1 to 9.8
sPAP/W, mm Hg 0.42  0.40 0.42  0.37 0.001 0.99 0.24 0.47 to 0.47
Values are mean  SD.
CMR ¼ cardiac magnetic resonance; CO ¼ cardiac output; ExCMRip ¼ exercise cardiac magnetic resonance imaging combined with invasive pulmonary artery pressure es-
timates; mPAP ¼ mean pulmonary artery pressure; mPAP/CO ¼mean pulmonary artery to cardiac output slope; sPAP ¼ systolic pulmonary artery pressure; sPAP/CO ¼ systolic
pulmonary artery pressure to cardiac output slope; sPAP/W ¼ systolic pulmonary artery pressure to workload (in Watts) slope; SV ¼ stroke volume.
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7measures of RV function during exercise against a
reference standard.
ACCURACY OF PAP ESTIMATION USING EXERCISE
ECHOCARDIOGRAPHY. Despite its role as the primary
screening tool to detect pulmonary hypertension, the
feasibility and robustness of Doppler echocardiogra-
phy to accurately assess sPAP has been questioned,
particularly during exercise (2,13). Compared with
previous studies, we found a signiﬁcantly higher
feasibility of PAP estimation by echocardiography,
which is likely explained by the use of colloid-
agitated contrast enhancement (13,14). Moreover,
the use of multipoint exercise measurements enabled
PAP/CO slope determination in 87% of subjects,
even when PAP could not be determined at peak
intensity exercise. This technique has signiﬁcant
advantages over the more commonly used method
of comparing rest values with a single “peak exer-
cise” value obtained when imaging constraints are
greatest.
The use of agitated contrast enhancement may also
explain the higher precision of sPAP estimates
compared with some previous studies (2,15), although
there was a tendency to overestimate sPAP, which
may also be a consequence of contrast enhancement
due to broadening of the spectral Doppler signal (14).
Some of this “overestimation” may also be due to
the fact that sPAP was generally estimated from
the highest tricuspid regurgitant velocity signals,
whereas the invasive measurement of sPAP wasrecorded as the average of maximal values. This
averaging can lead to signiﬁcantly lower values,
especially during exercise when the respiratory vari-
ation in sPAP is considerable.
Interestingly, although there was no signiﬁcant
bias between invasive sPAP and echocardiographic
estimates, invasive mPAP values were signiﬁcantly
lower than echocardiographic estimates. mPAP is not
measured directly using echocardiography, and,
thus, accuracy is dependent on extrapolation from
sPAP conversions. When we used the regression
equation from our own invasive data, we found that
much of the overestimation of echocardiography-
derived mPAP was in fact due to a slightly dif-
ferent regression equation in our cohort compared
with the Chemla formula. We cannot exclude that
the different regression equation in our study is
explained by the use of ﬂuid-ﬁlled catheters as
opposed to high-ﬁdelity micromanometers in the
study by Chemla et al. (11). Also, the inclusion of
CTEPH patients (with and without PEA) may have
inﬂuenced the relationship between sPAP and mPAP
(16), even though exclusion of these patients did not
alter our results.
PULMONARY VASCULAR PRESSURE/FLOW AND
PRESSURE/WORKLOAD RELATIONSHIPS. When
differentiating a normal from an abnormal pulmonary
vascular response to exercise, it is important to
interpret changes in PAP against CO or workload (4).
Noninvasive and invasive studies have suggested that
FIGURE 4 Comparison of Pulmonary Vascular Pressure/Flow and Pressure/Workload Relationships by Echocardiography and ExCMRip
Correlation coefﬁcients with 95% conﬁdence intervals (A through C) and Bland-Altman plots (B through F) of the slopes of mean PAP to CO
(mPAP/CO slopes) (A), of systolic pulmonary artery pressure to cardiac output (sPAP/CO slopes) (B), and sPAP to workload in Watts (sPAP/W
slopes) (C). CO ¼ cardiac output; other abbreviations as in Figures 2 and 3.
Claessen et al. J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . - , N O . - , 2 0 1 5
Echocardiography for Pulmonary Vascular and RV Function - 2 0 1 5 :- –-
8the slope of mPAP/CO ranges should not exceed 3.0
mm Hg/l/min in healthy subjects (1). We found that
mPAP/CO slopes obtained with echocardiography
were consistently higher than those obtained withExCMRip. This resulted from both overestimation of
mPAP, on the one hand, and underestimation of CO,
on the other, particularly at peak exercise intensity.
Nevertheless, the echocardiography-derived mPAP/CO
FIGURE 5 Measurement of RV Functional Reserve by Echocardiography and ExCMRip
Correlations between RVEF and right ventricular fractional area change (RVFAC) (A) and tricuspid annular plane systolic excursion (TAPSE) (B),
respectively, at both rest (solid lines) and peak exercise (dashed lines). (C) Relationship between resting (solid line) and peak exercise (dashed
line) right ventricular end-systolic pressure/volume ratio (RVESPVR) by ExCMRip and right ventricular end-systolic pressure/area ratio
(RVESPAR) by echocardiography. (D) Correlation, with 95% conﬁdence intervals, of the ratios of peak exercise with resting RVESPVR and
RVESPAR. Abbreviations as in Figures 2 and 3.
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9slope predicted an abnormal pulmonary vascular
response in the majority of subjects in whom ExCMRip
values were abnormal. Even better accuracy was
found for the slopes of sPAP to exercise intensity in
Watts rather than CO. In general, determination of
PAP to CO is preferred over workload because the
main determinant of PAP is ﬂow (1). However, despite
the marked interindividual variability of CO at any
given workload, our data demonstrate that the
increase in CO relative to the increase in workload is infact very similar among all study subjects. Moreover,
we demonstrate that the sPAP-to-workload relation-
ship can be used to identify pathology. This may be
a simpler and more pragmatic approach to include
evaluation of pulmonary vascular reserve in clinical
practice by avoiding the need for CO quantiﬁcation.
RV FUNCTIONAL RESERVE. Although some studies
have analyzed pulmonary vascular responses to ex-
ercise, there are very few data assessing changes in
RV function during exercise. Exercise CMR has
FIGURE 6 Accuracy of Echocardiography to Assess Pulmonary Vascular and RV Reserve
(A) Receiver-operating characteristic curves for echocardiographic pulmonary vascular pressure/ﬂow and pressure/workload relationships.
Simpliﬁed relationships between sPAP and exercise intensity have similar accuracy compared with echocardiography-derived sPAP and mPAP/
CO slopes to identify abnormal pulmonary vascular reserve. (B) Receiver-operating characteristic curves for right ventricular end-systolic
pressure/volume and pressure/area relationships to identify patients with impaired right ventricular contractile reserve. Abbreviations as in
Figures 3 to 5.
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10emerged as a promising technique enabling accurate
and reproducible quantiﬁcation of biventricular vol-
umes during strenuous exercise (7). However,
although exercise CMR offers superb insights into the
mechanics and quantiﬁcation of impaired cardiac
reserve, simpler tests are needed for clinical practice.
In this study, we found a good correlation between
echocardiographic measurement of exercise-induced
RV dimensional changes, such as RV fractional area
change and tricuspid annular plane systolic excur-
sion, and RVEF obtained by ExCMRip. However, due
to the inﬂuence of load on these measures, they tend
to reﬂect right ventricular-arterial coupling rather
than measures of RV contractility per se (9). To
distinguish between RV dysfunction and/or patho-
logical increases in pulmonary vascular load, we
combined sPAP and RV end-systolic area using
echocardiography to calculate RVESPAR as a surro-
gate of RV contractility (9). Our current results show
that exercise-induced increases in RVESPAR correlate
strongly with increases in RVESPVR obtained by
ExCMRip. Recent data from our group indicated that
CTEPH and post-PEA patients have higher RV
contractility at rest compared with healthy subjects to
compensate for increases in RV afterload (8). How-
ever, the right ventricle’s ability to further increase
contractility with exercise is diminished in thesepatients, resulting in an uncoupling of RV contrac-
tility and pulmonary arterial load (8). Resting
RVESPVR and RVESPAR are higher in CTEPH pa-
tients, whereas the ratios of peak exercise to resting
RVESPVR and RVESPAR are signiﬁcantly reduced.
Therefore, the ratio of peak exercise to resting
RVESPAR may be a promising noninvasive index of
RV contractile reserve. It has been shown for the
left ventricle that the end-systolic pressure-volume
ratio response to exercise using echocardiography
predicts clinical outcome and provides additional
information beyond ejection fraction (17,18). The
same approach, however, remains to be tested for
the right ventricle.
STUDY LIMITATIONS. There are several potential
limitations to our study. First, the subject population
consisted of a mixture of various diagnostic groups
that may not reﬂect the population in a clinical
setting and may have artiﬁcially improved correla-
tions among measures. Second, the exercise ExCMRip
and exercise echocardiography tests cannot be per-
formed simultaneously because of technical consid-
erations. Furthermore, because the study protocol
consisted of several exercise tests, we thought
that performing all the measurements on 1 day was
not feasible. However, all subjects underwent the
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: Echocardiogra-
phy is a feasible, reproducible, and accurate tool for the evaluation
of pulmonary vascular and RV functional reserve during exercise in
clinical practice.
COMPETENCY IN PATIENT CARE AND PROCEDURAL
SKILLS: When evaluating pulmonary vascular reserve in clinical
practice, simpliﬁed relationships between sPAP and exercise in-
tensity can be used to identify pathology and represent a simpler
clinical tool by avoiding the need for CO quantiﬁcation.
TRANSLATIONAL OUTLOOK: These novel exercise parame-
ters offer considerable potential for identifying clinically relevant
pulmonary vascular disease and RV dysfunction at an early stage.
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11ExCMRip protocol within 24 h after Doppler exercise
echocardiography. The augmentation of heart rate
with increasing exercise intensity was slightly lower
during the exercise echocardiography protocol des-
pite cycling at the same workloads. Although this
resulted in differences in heart rate at each level, the
effect on the pressure/output relationship should not
have been affected. Some of the inaccuracy between
echocardiographic and invasive measurement of PAP
was due to the fact that we did not include right atrial
pressure estimates by echocardiography. In an anal-
ysis of a subgroup who underwent invasive right
atrial pressure measures during exercise, we de-
monstrated a tendency to underestimate sPAP by
echocardiography in pulmonary hypertension pa-
tients in whom right atrial pressure increased during
exercise. Thus, right atrial pressure cannot be as-
sumed to remain constant throughout exercise.
Furthermore, although multipoint PAP/CO slope
determination was feasible in the majority of in-
dividuals, the success rate of obtaining PAP at peak
exercise was signiﬁcantly lower. Finally, end-systolic
pressure was approximated as sPAP in all subjects. It
has been demonstrated that end-systolic pressure
varies according to the presence of pathology such
that it approximates mPAP in normotensive subjects,
whereas it is best estimated as sPAP with the devel-
opment of pulmonary hypertension (19). However, as
the purpose of the testing is to distinguish whether
the exercise response is abnormal, an assumptive
compromise is required. Nevertheless, because con-
tractile reserve is derived as the change in RVESVPR
or RVESPAR and given the constant relationship be-
tween sPAP and mPAP during exercise (20), the effect
of these assumptions is minimized.
CONCLUSIONS
Echocardiography is a feasible and accurate tool for
the evaluation of pulmonary vascular and RVfunctional reserve during exercise in clinical prac-
tice. Simpliﬁed relationships between sPAP and ex-
ercise intensity in Watts can be used to identify
pathology and may represent a simpler clinical tool
by avoiding the need for CO quantiﬁcation. Further
studies are needed to determine the clinical rele-
vance of these novel exercise parameters for iden-
tifying pulmonary vascular disease and RV
dysfunction at an early stage.
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